Brittany brings visionary thinking and efficient problem-solving skills to our Strategic Transactions & Licensing group. Brittany’s practice spans a broad array of industries and technologies, including biotechnology, pharmaceuticals, healthcare, medical devices, software, hardware, information technology, transportation, energy, and media. She structures and negotiates commercial contracts regarding the licensing, development and commercialization of intellectual property and technology assets, including development agreements, licensing agreements, collaboration agreements, pre-clinical and clinical arrangements, supply agreements, and manufacturing and distribution agreements. She represents start-up/emerging growth companies in commercial transactions with many large U.S. and international companies, including Amgen, Facebook, Janssen Biotech, and Novartis.

In addition, Brittany advises clients on rapidly-evolving data privacy regulations, laws and best practices. She helps clients navigate a broad range of complex technology transactional matters, including issues arising from mergers and acquisitions and venture capital investments.

Brittany currently serves as a member of the Internal Development Committee of the firm’s People of Color Affinity Group.

Brittany has maintained a robust pro bono practice, specifically with respect to correcting and preventing the conviction of innocent prisoners. She was a Student Attorney for the Michigan Innocence Clinic in law school, conducted related pro bono work at Hogan Lovells US LLP, and is currently working with the California Western Innocence and Justice Clinic.

Brittany is also fluent in Cantonese.

Prior to joining Gunderson Dettmer, Brittany was an M&A associate in the Silicon Valley office of Hogan Lovells US LLP.